Department of Aesthetic, Plastic and Maxillofacial Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Department of Plastic Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.
BMJ Open. 2019 Jan 15;9(1):e021645. doi: 10.1136/bmjopen-2018-021645.
Based on the principles of the ideal skin closure technique, we previously described a suture technique (wedge-shaped excision and modified buried vertical mattress suture (WE-MBVMS)) that could provide excellent outcomes for the most demanding surfaces. However, adequate clinical comparative evidence supporting improved outcomes is lacking. Thus, the purpose of this protocol is to establish the feasibility of conducting a fully randomised controlled trial (RCT) comparing the clinical effectiveness of WE-MBVMS with a buried intradermal suture (BIS) in closing thoracic incision.
This study is a feasibility RCT of WE-MBVMS and BIS in patients undergoing surgery for costal cartilage harvesting. Seventy-eight participants are expected to participate in the study and will be randomised in a ratio of 1:1 to WE-MBVMS or BIS. Trial feasibility will be assessed by the number of participants assessed for eligibility, recruitment rates, reasons for ineligibility or non-participation, time for interventions, withdrawal and retention at all follow-up points (3, 6 and 12 months), follow-up rates and reasons for withdrawing from the trial. In addition, clinical data regarding the cosmetic results of scars will be collected to inform the sample size for a fully powered RCT.
This study has been approved by The First Affiliated Hospital of Xi'an Jiaotong University Institutional Review Board (XJTU1AF2017LSK-120). The findings will be published in peer-reviewed journals.
ChiCTR-INR-17013335; Pre-results.
基于理想皮肤缝合技术的原则,我们之前描述了一种缝合技术(楔形切除和改良埋没垂直褥式缝合(WE-MBVMS)),它可以为最具挑战性的表面提供出色的效果。然而,缺乏支持改善效果的充分临床对比证据。因此,本方案的目的是确定对胸切口进行 WE-MBVMS 与埋没皮内缝合(BIS)的临床效果进行完全随机对照试验(RCT)的可行性。
这是一项 WE-MBVMS 与 BIS 用于肋软骨切除术后患者的可行性 RCT。预计将有 78 名参与者参与研究,并将按照 1:1 的比例随机分为 WE-MBVMS 或 BIS 组。通过评估合格人数、招募率、不合格或不参与的原因、干预时间、所有随访点(3、6 和 12 个月)的退出和保留率、随访率以及退出试验的原因来评估试验的可行性。此外,还将收集有关疤痕美容效果的临床数据,为全面效力 RCT 提供样本量信息。
本研究已获得西安交通大学第一附属医院机构审查委员会(XJTU1AF2017LSK-120)的批准。研究结果将发表在同行评议的期刊上。
ChiCTR-INR-17013335;预结果。